Masimo Corporation (NASDAQ:MASI) is set to announce its earnings results after the market closes on Tuesday, October 31st. Analysts expect the company to announce earnings of $0.53 per share for the quarter. Masimo Corporation has set its FY17 guidance at $2.80 EPS.

Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $192.90 million for the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. Masimo Corporation’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period last year, the business posted $0.57 EPS. On average, analysts expect Masimo Corporation to post $2.8 EPS for the current fiscal year and $2.53 EPS for the next fiscal year.

Masimo Corporation (MASI) opened at 88.65 on Tuesday. The stock has a market capitalization of $4.60 billion, a P/E ratio of 14.53 and a beta of 0.82. The firm’s 50-day moving average price is $85.86 and its 200 day moving average price is $89.57. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71.

ILLEGAL ACTIVITY WARNING: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at

In related news, Director Sanford Fitch sold 11,000 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total value of $959,750.00. Following the transaction, the director now owns 72,249 shares of the company’s stock, valued at $6,303,725.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 16.60% of the company’s stock.

A number of research firms have recently weighed in on MASI. Roth Capital upped their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. BidaskClub lowered Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Stifel Nicolaus began coverage on Masimo Corporation in a research report on Monday, July 10th. They set a “buy” rating and a $105.00 price objective on the stock. Finally, BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Monday, August 14th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the stock. Masimo Corporation has an average rating of “Hold” and a consensus price target of $97.00.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Earnings History for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with's FREE daily email newsletter.